NCOR2 mediates the transcriptional repression activity of some nuclear receptors by promoting chromatin condensation, thus preventing access to basal transcription (Lee et al., 2022) and is a novel candidate gene for the migraine-epilepsy phenotype (Nuottamo et al., 2022). The gene discussed is NCOR2; the disease is migraine disorder.